Qsymia is a prescription weight loss medication that is designed to help people reduce their appetite and lose weight. It is FDA-approved for use in adults with obesity and is considered safe for long ...
The approval was based on data from a phase 4 study which included patients 12 to 17 years of age with a BMI at the 95th percentile or greater standardized for age and sex. The Food and Drug ...
WASHINGTON -- For the second time in a month, the Food and Drug Administration has approved a prescription weight-loss medication for the nation's 78 million obese adults after maintaining for years ...
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., announced today that QSYMIA® (phentermine and topiramate extended-release capsules ...
-Data published in Surgery for Obesity and Related Diseases also show that patients in the Qsymia group lost more than twice as much weight during preoperative treatment compared with control group- ...
Qsymia is a combination of two medications that have long been used in weight management. One is an appetite suppressant. The other reduces cravings for food. Prescription diet drugs have had a ...
The pill, called Qsymia, is designed for those who are overweight and have at least one weight-related condition, such as high blood pressure or diabetes. It is expected to help them lose 10 percent ...
NEW YORK (Reuters) - U.S. drug regulators approved Vivus Inc's obesity drug late on Tuesday, the second new diet pill approved in the last month, as health advocates push for new solutions to combat ...
<span>The U.S. Food and Drug Administration approved the new weight loss drug Qsymia on Tuesday, adding to a very skimpy arsenal of drugs Americans can take to battle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback